Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa-Reference-Cited by-同舟云学术

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa

Published:2008-05 Issue:22 Volume:26 Page:2788-2795
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Jaoko Walter,Nakwagala Frederick N.,Anzala Omu,Manyonyi Gloria Omosa,Birungi Josephine,Nanvubya Annet,Bashir Farah,Bhatt Kirana,Ogutu Hilda,Wakasiaka Sabina,Matu Lucy,Waruingi Wambui,Odada Jane,Oyaro Micah,Indangasi Jackton,Ndinya-Achola Jeckonia,Konde Carol,Mugisha Emmanuel,Fast Patricia,Schmidt Claudia,Gilmour Jill,Tarragona Tony,Smith Carol,Barin Burc,Dally Len,Johnson Bruce,Muluubya Andrew,Nielsen Leslie,Hayes Peter,Boaz Mark,Hughes Peter,Hanke Tomáš,McMichael Andrew,Bwayo Job,Kaleebu Pontiano

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference27 articles.

1. Design and construction of an experimental HIV-I vaccine for a year-2000 clinical trial in Kenya;Hanke;Nat Med,2000

2. Distinct recognition of clade A HIV-1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa;Dorrell;J Virol,1999

3. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of immunodominant determinant of the human immunodeficiency virus envelope protein;Takahashi;J Exp Med,1989

4. Characterization of the peptide-binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from SIV;Allen;J Immunol,1998

5. Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya;Hanke;Vaccine,2002

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of SARS-CoV-2 AstraZeneca vaccine on safety and blood elements of Egyptian healthcare workers;Indian Journal of Occupational and Environmental Medicine;2023

2. Does the number of doses matter? A qualitative study of HPV vaccination acceptability nested in a dose reduction trial in Tanzania;Tumour Virus Research;2021-12

3. Epidemiological and clinical implications of asymptomatic malaria and schistosomiasis co-infections in a rural community in western Kenya;BMC Infectious Diseases;2021-09-09

4. Clinical laboratory reference values in adults in Kisumu County, Western Kenya; hematology, chemistry and CD4;PLOS ONE;2021-03-30

5. Clinical laboratory hematology reference values among infants aged 1month to 17 months in Kombewa Sub-County, Kisumu: A cross sectional study of rural population in Western Kenya;PLOS ONE;2021-03-17